Showing results (681-690 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|May 15, 2020
Outcomes Following Immune Checkpoint Inhibitor Treatment of Patients With Microsatellite Instability-High Cancers: A Systematic Review and Meta-analysisFausto Petrelli, Michele Ghidini, Antonio Ghidini, et al.
JAMA Oncology|February 2, 2023
Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin LymphomaYvonne M Geurts, Rebecca Shakir, Georgios Ntentas, et al.
JAMA Oncology|February 16, 2023
Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical TrialsMark A Socinski, Robert M Jotte, Federico Cappuzzo, et al.
JAMA Oncology|February 16, 2023
Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast CancerKent F Hoskins, Gregory S Calip, Hsiao-Ching Huang, et al.
JAMA Oncology|February 23, 2023
Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050Simiao Chen, Zhong Cao, Klaus Prettner, et al.
JAMA Oncology|November 17, 2022
Association of Residential Racial and Economic Segregation With Cancer Mortality in the USLu Zhang, Rui Gong, Lu Shi, et al.
JAMA Oncology|November 17, 2022
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLCMehrdad Rakaee, Elio Adib, Biagio Ricciuti, et al.
JAMA Oncology|November 26, 2025
Metastatic Recurrence Among Adolescents and Young Adults With CancerAnn Brunson, Ted Wun, Renata Abrahão, et al.
JAMA Oncology|December 26, 2025
Immune Checkpoint Inhibitor-Induced Diabetes Across National Cancer Institute Trials That Included PD-1 or PD-L1 AgentsZoe E Quandt, Shanda Finnigan, Vanessa Hill, et al.
JAMA Oncology|February 12, 2026
Ancestry-Associated Performance Variability of Open-Source AI Models for EGFR Prediction in Lung CancerMehrdad Rakaee, Amin H Nassar, Masoud Tafavvoghi, et al.
Pageof 161